This year, the Puget Sound research community was visited by the Vice President, Joe Biden. The visit has made the community very popular. One of the growing communities in the area that the vice president visited was Seattle Genetics, a company that has transformed the lives of many cancer patients in the recent past.
Seattle Genetics is one of the growing Biotechnology pharmaceutical companies in the world, and it is putting a lot of effort to ensure that its first drug which was introduced several years ago is used by the growing number of cancer patients in the world. The company is planning to hire more professionals to enable it expand its services to the consumers.
Cancer is one of the most feared diseases in the world. However, the number of people suffering from the diseases continues to grow every day. Seattle Genetics wants to increases its products so that it can help these individuals. Currently, Seattle Genetics, under the leadership of its founder and CEO is working hard to commercialize its first drug, known as Adcetris. Adcetris is being tested on several types of lymphomas.
Adcetris, the only product from Seattle Genetics is mostly used by patients who are fighting lymphomas. The product is doing quite well in the places it has been taken, and in Canada and the United States, it registered very high sales last year. Takeda Pharmaceuticals, one of the partners of Seattle Genetics is currently trying to introduce the product in other parts of the world.
Apart from Adcetris, Seattle Genetics has not been able to introduce any other cancer
drug in the market. However, reports from the pharmaceutical company say that more drugs are being developed. Twelve drugs are currently being developed by Seattle Genetics CEO, and they will all be made for individuals suffering from different types of cancer.
33A, the second product from the institution will soon be introduced to the market this year. It will be used to treat individuals with acute myeloid leukemia. Seattle Genetics will also be introduced a drug for bladder cancer and breast cancer.
Seattle Genetics has done so well under the leadership of Dr. Clay Siegall, its CEO and Founder. Dr. Clay is experienced in the pharmaceutical world, and he has done a lot to cure individuals suffering from cancer.